Ionis Pharmaceuticals | IONS - 利息收入



金融业
股票价格
USD 44.12
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 6.41B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


利息收入 更改 日
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Arrowhead Research USD 16.93M 66K 2026-06
Astellas Pharma JPY 4.12B 2.94B 2024-03
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Celltrion KRW 779M 157.66M 2026-03
Exelixis USD 14.21M 1.92M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Kangmei Pharma CNY 2.44M 635.78K 2026-03
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Medical Developments International AUD 174K 31K 2024-12
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
OPKO Health USD 3.01M 16K 2026-03
Pfizer USD -0.04 115M 2026-06
Pharma Mar EUR 1.63M 3.17M 2025-12
Qiagen NV USD 10.56M 9.44M 2026-03
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Sartorius EUR 14.8M 5.3M 2026-06
Tilray USD 12.83M 20.19M 2024-05
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06
Zealand Pharma A/S 74M 28.41M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M 2026-03